Application value of total arterial revascularization combined with coronary artery bypass grafting in patients with left ventricular dysfunction

严哲,张小涛,李晓恒
DOI: https://doi.org/10.3760/cma.j.cn115689-20220123-00412
2022-01-01
Abstract:Objective:To analyze the value of total arterial revascularization (TAR) combined with coronary artery bypass grafting (CABG) in patients with low left ventricular dysfunction, that is, with left ventricular ejection fraction (LVEF) ≤ 35%.Methods:The clinical data of 72 patients with left ventricular dysfunction after CABG in Luoyang Central Hospital Affiliated to Zhengzhou University from January 2018 to March 2021 were collected retrospectively. According to the operation methods, patients were divided into routine group and TAR group, with 36 cases in each group. Patients in the routine group were treated by left internal mammary artery combined with great saphenous vein CABG; while patients in the TAR group were treated by TAR combined with CABG (via bilateral internal mammary artery, left or/and right radial artery). The perioperative conditions, long-term vascular patency rate, myocardial function assessed by 24 h creatine kinase isoenzyme (24 h CK-MB) and 24 h cardiac troponin T (24 h cTnT), cardiac ultrasound indexes including left ventricular end-diastolic diameter (LVEDD) and LVEF, incidence of complications, and adverse prognosis were compared between the two groups.Results:Compared with the routine group, the TAR group had longer operation time and shorter postoperative ventilator assistance time ( P<0.05). The vascular patency rate of the TAR group (91.67%, 33/36) was higher than that of the routine group (72.22%, 26/36) 6 months after operation ( P<0.05). Compared with the routine group, the levels of 24 h CK-MB and 24 h cTnT in the TAR group were lower (all P<0.05); 6 months after operation, the TAR group had lower LVEDD and higher LVEF, compared with the routine group ( P<0.05). There was no significant difference in the incidence of complications between the two groups ( P>0.05). The incidence of poor prognosis in the TAR group (8.33%, 3/36) was lower than that in the routine group (27.78%, 10/36), P<0.05. Conclusions:For patients with left ventricular dysfunction, TAR combined with CABG has a relatively long operation time, however, it can shorten postoperative ventilator assistance time, improve cardiac function and myocardial function, prevent complications, and reduce the incidence of poor prognosis.
What problem does this paper attempt to address?